Share-based Payment Arrangement, Expense of Greenwich LifeSciences, Inc. from 31 Mar 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Greenwich LifeSciences, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2023 to 31 Mar 2024.
  • Greenwich LifeSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $4,221,106, a 129% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)

Greenwich LifeSciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $4,221,106 +$2,378,088 +129% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q1 2023 $1,843,018 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1

Greenwich LifeSciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,626,584 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.